Profitability Ratios
| Ratio |
Value |
| GP Margin |
49.8% |
| EBIT Margin |
-8.9% |
| EBITDA Margin |
-4.7% |
| Operating Margin |
-8.8% |
| Pretax Margin |
-9.4% |
| Cont. Ops Margin |
-9.7% |
| Net Margin |
-9.7% |
| Bottom Line Margin |
-9.7% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.15 |
| Quick Ratio |
1.26 |
| Solvency Ratio |
-0.132 |
| Cash Ratio |
0.54 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.09 |
| Forward PEG |
0.09 |
| Price/Book |
0.67 |
| Price/Sales |
0.74 |
| Price/FCF |
12.09 |
| Price/Op Cash Flow |
6.98 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1202 |
| Debt/Equity |
0.1659 |
| Debt/Capital |
0.1423 |
| Long-Term Debt/Capital |
0.1040 |
| Financial Leverage |
1.38 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
3.36 |
| Operating Cash Flow Ratio |
0.452 |
| Operating Cash Flow/Sales |
10.7% |
| Free Cash Flow/Operating Cash Flow |
57.7% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-2.46 |
| Interest Coverage |
-15.4000 |
| Short-Term Operating Cash Flow Coverage |
7.32 |
| Operating Cash Flow Coverage |
0.58 |
| Capital Expenditure Coverage |
2.36 |
| Dividend + Capital Expenditure Coverage |
2.36 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
15.11 |
| EPS |
-1.463 |
| Debt/Share |
2.8685 |
| Cash/Share |
1.94 |
| Book Value/Share |
16.77 |
| Tangible BV/Share |
5.72 |
| Equity/Share |
16.77 |
| Operating Cash Flow/Share |
1.610 |
| Capital Expenditure/Share |
0.681 |
| FCF/Share |
0.929 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.026 |
| Earnings Before Tax/EBIT |
1.075 |
| Price/Fair Value |
0.67 |
| Debt/Market Cap |
0.1929 |
| Effective Tax Rate |
-2.6% |
| Enterprise Value Multiple |
-16.88 |
AVNS - Avanos Medical, Inc.